Surgical strategies for scleroderma
10.3760/cma.j.cn114453-20220330-00090
- VernacularTitle:硬皮病的外科治疗策略
- Author:
Jiaqi QIN
1
;
Bin FANG
;
Jiahao HE
;
Xintao WANG
;
Qingfeng LI
;
Yun XIE
Author Information
1. 上海交通大学医学院附属第九人民医院整复外科，上海 200011
- Keywords:
Scleroderma;
Surgical treatment;
Autologous fat graft;
Botulinum toxins;
Regeneration treatment
- From:
Chinese Journal of Plastic Surgery
2023;39(9):1020-1027
- CountryChina
- Language:Chinese
-
Abstract:
Scleroderma is a rare disease which requires multidisciplinary treatment. Drug-based therapy can partially alleviate or end the progression of the disease, but cannot reverse the lesions that have occurred. Scleroderma patients who seek care in plastic surgery has gradually increased in recent years. With the understanding of the regenerative role of fat and adipose stem cells, physicians have found that surgical treatment of scleroderma can improve morphology while reversing the state of the diseased tissue, acting as a local treatment or slowing progression. This paper briefly described the etiology and classification of scleroderma, analyzed the current status of scleroderma treatment and focused on the surgical treatment strategy of scleroderma, providing guidelines for the surgical management of scleroderma.
